Skip to Content
Merck
  • A cDNA RDA protocol using solid-phase technology suited for analysis in small tissue samples.

A cDNA RDA protocol using solid-phase technology suited for analysis in small tissue samples.

Biomolecular engineering (2000-10-24)
J Odeberg, T Wood, A Blücher, J Rafter, G Norstedt, J Lundeberg
ABSTRACT

cDNA representational difference analysis (cDNA RDA) is a PCR-based subtractive enrichment procedure for the cloning of differentially expressed genes. In this study, we have further developed the procedure to take advantage of solid-phase technology, and to facilitate the use of RDA when starting material is limited. Several parameters of the PCR-based generation of cDNA representations were investigated, and a solid-phase based purification step was introduced to simplify removal of digested adapter-ends and uncleaved fragments. The use of magnetic particles increased the speed of the method, and also eliminated the risk of carry-over contamination between iterative steps of subtraction and PCR amplification. The modified protocol was evaluated in monitoring differences in gene expression in (i) a rat system consisting of livers with and without growth hormone treatment, and in (ii) a human system consisting of normal colon and colon cancer.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Poly(methyl methacrylate-co-ethylene glycol dimethacrylate), 50 μm particle size